HCV NS3-NS4A protease inhibition using VX-950, also known as telaprevir

摘要

Disclosed is the use of VX-950, known as telaprevir, or a pharmaceutically acceptable salt thereof in the preparation of a medicament for treating a disease or disorder responsive to inhibition of genotype-2 Hepatitis-C virus (HCV) NS3-NS4A protease or genotype-3 Hepatitis-C virus (HCV) NS3-NS4A protease, including a HCV genotype-2 infection or a HCV genotype-3 infection.